Results 131 to 140 of about 166,968 (308)
Abstract Background Early enteral nutrition is recommended for critically ill patients. However, feeding an ischemic gastrointestinal tract with enteral nutrition may lead to gut necrosis. Although gut tolerance of enteral nutrition is assessed by various symptoms, none of them provide conclusive evidence of gut ischemia. We investigated the blood flow
Tomonori Narita +8 more
wiley +1 more source
Abstract Objectives Pediatric intestinal pseudo‐obstruction (PIPO) is a severe bowel motility disorder characterized by impaired propulsion of gastrointestinal contents without mechanical obstruction. PIPO encompasses congenital and acquired disorders, including neuropathies, myopathies, and mesenchymopathies.
Sharon Wolfson +8 more
wiley +1 more source
MP33-13 CHARACTERISTICS OF HIGH LOWER URINARY TRACT SYMPTOM (LUTS) BOTHER IN INDIVIDUALS SEEKING CARE FOR LUTS [PDF]
Nnenaya A. Mmonu +16 more
openalex +1 more source
ABSTRACT Background and Objective Palliative surgery in oncology aims to relieve symptoms, improve quality of life, and respect patient autonomy in advanced cancer. This study aimed to develop evidence‐based recommendations for safely indicating and performing palliative surgeries in Brazil, considering clinical, ethical, and multidisciplinary aspects.
Audrey Cabral Ferreira de Oliveira +15 more
wiley +1 more source
MP35-10 IS THERE ROOM FOR BEHAVIORAL AND MODIFIABLE HEALTH-RELATED TARGETS IN THE LOWER URINARY TRACT SYMPTOMS SCENARIO [PDF]
Osamu Ikari +6 more
openalex +1 more source
Objectives This study aims to evaluate the diagnostic value of a novel multimodal approach combining transperineal ultrasound (TPUS), transrectal dual‐plane ultrasound, and shear wave elastography (SWE) in predicting stress urinary incontinence (SUI). Methods A total of 70 women diagnosed with SUI and 110 healthy controls were included.
Yidan Wang +6 more
wiley +1 more source
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo +11 more
wiley +1 more source
Comination pharmacotherapy of lower urinary tract symptoms [PDF]
Marcela Fontana
openalex +1 more source
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction [PDF]
Eugenia Fragalà +10 more
openalex +1 more source
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson +12 more
wiley +1 more source

